Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Kirsch

Showing results (301-310 of 358) with videos related to

Pageof 36
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 18, 2026
ESTRO clinical practice guideline on radiotherapy for adult soft tissue sarcoma of the extremities and trunk wall - Endorsed by ASTROSiyer Roohani, Mateusz Jacek Spałek, Ninna Aggerholm-Pedersen, et al.
JCI Insight|September 8, 2022
Loss of ATRX promotes aggressive features of osteosarcoma with increased NF-κB signaling and integrin bindingSuzanne Bartholf DeWitt, Sarah Hoskinson Plumlee, Hailey E Brighton, et al.
International Journal of Radiation Oncology, Biology, Physics|December 17, 2023
Preclinical Evaluation of the ATR Inhibitor BAY 1895344 as a Radiosensitizer for Head and Neck Squamous Cell CarcinomaDiana A Odhiambo, Allison N Pittman, Ashlyn G Rickard, et al.
International Journal of Radiation Oncology, Biology, Physics|May 17, 2025
Retraction notice to "Efficacy of Sunitinib and Radiotherapy in Genetically Engineered Mouse Model of Soft-Tissue Sarcoma" Int J Radiat Oncol Biol Phys, 2009; 74(4), pp 1207-1216Sam S Yoon, Lars Stangenberg, Yoon-Jin Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 31, 2025
Nrf2 hyperactivation as a driver of radiotherapy resistance and suppressed anti-tumor immunity in head and neck squamous cell carcinomaRutulkumar Patel, Kalil Saab, Lixia Luo, et al.
Cancer|March 23, 2012
Intraoperative detection and removal of microscopic residual sarcoma using wide-field imagingJeffrey K Mito, Jorge M Ferrer, Brian E Brigman, et al.
International Journal of Radiation Oncology, Biology, Physics|June 24, 2009
Efficacy of sunitinib and radiotherapy in genetically engineered mouse model of soft-tissue sarcomaSam S Yoon, Lars Stangenberg, Yoon-Jin Lee, et al.
The Journal of Clinical Investigation|May 18, 2023
Atrx deletion impairs CGAS/STING signaling and increases sarcoma response to radiation and oncolytic herpesvirusWarren Floyd, Matthew Pierpoint, Chang Su, et al.
International Journal of Radiation Oncology, Biology, Physics|January 6, 2024
The Next Chapter in Immunotherapy and Radiation Combination Therapy: Cancer-Specific PerspectivesAmy J Wisdom, Christopher A Barker, Joe Y Chang, et al.
Nature|August 2, 2019
Dietary methionine influences therapy in mouse cancer models and alters human metabolismXia Gao, Sydney M Sanderson, Ziwei Dai, et al.
Pageof 36

Showing results (301-310 of 358) with videos related to

Sort By:
Pageof 36
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 18, 2026
ESTRO clinical practice guideline on radiotherapy for adult soft tissue sarcoma of the extremities and trunk wall - Endorsed by ASTROSiyer Roohani, Mateusz Jacek Spałek, Ninna Aggerholm-Pedersen, et al.
JCI Insight|September 8, 2022
Loss of ATRX promotes aggressive features of osteosarcoma with increased NF-κB signaling and integrin bindingSuzanne Bartholf DeWitt, Sarah Hoskinson Plumlee, Hailey E Brighton, et al.
International Journal of Radiation Oncology, Biology, Physics|December 17, 2023
Preclinical Evaluation of the ATR Inhibitor BAY 1895344 as a Radiosensitizer for Head and Neck Squamous Cell CarcinomaDiana A Odhiambo, Allison N Pittman, Ashlyn G Rickard, et al.
International Journal of Radiation Oncology, Biology, Physics|May 17, 2025
Retraction notice to "Efficacy of Sunitinib and Radiotherapy in Genetically Engineered Mouse Model of Soft-Tissue Sarcoma" Int J Radiat Oncol Biol Phys, 2009; 74(4), pp 1207-1216Sam S Yoon, Lars Stangenberg, Yoon-Jin Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 31, 2025
Nrf2 hyperactivation as a driver of radiotherapy resistance and suppressed anti-tumor immunity in head and neck squamous cell carcinomaRutulkumar Patel, Kalil Saab, Lixia Luo, et al.
Cancer|March 23, 2012
Intraoperative detection and removal of microscopic residual sarcoma using wide-field imagingJeffrey K Mito, Jorge M Ferrer, Brian E Brigman, et al.
International Journal of Radiation Oncology, Biology, Physics|June 24, 2009
Efficacy of sunitinib and radiotherapy in genetically engineered mouse model of soft-tissue sarcomaSam S Yoon, Lars Stangenberg, Yoon-Jin Lee, et al.
The Journal of Clinical Investigation|May 18, 2023
Atrx deletion impairs CGAS/STING signaling and increases sarcoma response to radiation and oncolytic herpesvirusWarren Floyd, Matthew Pierpoint, Chang Su, et al.
International Journal of Radiation Oncology, Biology, Physics|January 6, 2024
The Next Chapter in Immunotherapy and Radiation Combination Therapy: Cancer-Specific PerspectivesAmy J Wisdom, Christopher A Barker, Joe Y Chang, et al.
Nature|August 2, 2019
Dietary methionine influences therapy in mouse cancer models and alters human metabolismXia Gao, Sydney M Sanderson, Ziwei Dai, et al.
Pageof 36